Trials / Conditions / Esophagogastric Junction
Esophagogastric Junction
5 registered clinical trials studyying Esophagogastric Junction.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | Assessing Durvalumab and FLOT Chemotherapy in Resectable Gastric and Gastroesophageal Junction Cancer NCT04592913 | AstraZeneca | Phase 3 |
| Completed | Intraperitoneal and Intravenous Paclitaxel Chemotherapy With Oral Capecitabine for Gastric Adenocarcinoma With NCT04034251 | National Cancer Institute (NCI) | Phase 2 |
| Completed | An Investigational Study of Immunotherapy Combinations With Chemotherapy in Patients With Gastric or Gastroeso NCT03662659 | Bristol-Myers Squibb | Phase 2 |
| Completed | Heated Intraperitoneal Chemotherapy and Gastrectomy for Gastric Cancer With Positive Peritoneal Cytology NCT03092518 | National Cancer Institute (NCI) | Phase 2 |
| Completed | A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of JNJ-42756493 in Patients With Advanc NCT01962532 | Janssen Research & Development, LLC | Phase 1 |